EMA Authorised: Trevicta (previously Paliperidone Janssen) (paliperidone palmitate) — Janssen-Cilag International NV

View source ↗

Summary

The European Medicines Agency authorised Trevicta, a brand-name long-acting paliperidone palmitate injection for schizophrenia, with Janssen-Cilag International…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Trevicta (paliperidone palmitate)

Snippet

Status: Authorised. Therapeutic area: Schizophrenia. MAH: Janssen-Cilag International NV. Decision date: 19/07/2024